Unusual vasovagal-type autonomic dysfunction secondary to immune checkpoint inhibitor therapy

被引：0

作者：

Danley, Kelsey ^{[1
]}

Fidler, Mary Jo ^{[2
]}

Sadaf, Aliyah ^{[1
]}

Okwuosa, Tochukwu M. ^{[3
]}

机构：

[1] Rush Univ, Med Ctr, Internal Med, Chicago, IL 60612 USA

[2] Rush Univ, Med Ctr, Oncol, Chicago, IL USA

[3] Rush Univ, Med Ctr, Dept Internal Med, Div Cardiol, Chicago, IL USA

来源：

BMJ CASE REPORTS | 2023年 / 16卷 / 02期

关键词：

Cancer; see Oncology; Cancer intervention; Cardiovascular system; ADVERSE EVENTS;

D O I：

10.1136/bcr-2022-251034

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present the case of a patient with oral squamous cell carcinoma treated with the programmed death ligand inhibitor, pembrolizumab, an immune checkpoint inhibitor. She subsequently developed vasovagal-type autonomic dysfunction thought to be secondary to the pembrolizumab. The patient's vasovagal symptoms resolved with the initiation of oral glucocorticoids.

引用

页数：3

共 50 条

[1] UNUSUAL CARDIOVASCULAR AUTONOMIC DYSFUNCTION SECONDARY TO IMMUNE CHECKPOINT INHIBITOR THERAPY
Danley, Kelsey T.
Fidler, Mary
Sadaf, Aliyah
Okwuosa, Tochi M.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2823 - 2823
[2] Endocrine dysfunction following immune checkpoint inhibitor therapy
Konda, Bhavana
Nabhan, Fadi
Shah, Manisha H.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2017, 24 (05) : 337 - 347
[3] Hemophagocytic Lymphohistiocytosis Secondary to Immune Checkpoint Inhibitor Therapy
Rajapakse, Pramuditha
Andanamala, Haripriya
WORLD JOURNAL OF ONCOLOGY, 2022, 13 (02) : 49 - 52
[4] EOSINOPHILIC PNEUMONIA SECONDARY TO IMMUNE CHECKPOINT INHIBITOR THERAPY WITH PEMBROLIZUMAB
Selvan, Kavitha
Strykowski, Rachel K.
Lee, Cathryn
Strek, Mary E.
Jablonski, Renea
CHEST, 2022, 162 (04) : 1282A - 1283A
[5] An Unusual Presentation of GI Complication Related to Immune Checkpoint Inhibitor Therapy
Naz, Sidra
Wang, Yinghong
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2541 - S2541
[6] Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac Dysfunction
Michel, Lars
Ferdinandy, Peter
Rassaf, Tienush
CURRENT HEART FAILURE REPORTS, 2024, 21 (03) : 214 - 223
[7] Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac Dysfunction
Lars Michel
Peter Ferdinandy
Tienush Rassaf
Current Heart Failure Reports, 2024, 21 : 214 - 223
[8] Concomitant Primary and Secondary Adrenal Insufficiency due to Immune Checkpoint Inhibitor Therapy
Montalvan, Eileen
Pasha, Mohammed Afraz
Jackson, Bethany
SOUTHERN MEDICAL JOURNAL, 2022, 115 (07) : 548 - 549
[9] Immune Checkpoint Inhibitor Therapy Toxicities
Jim, Heather S. L.
Knoop, Hans
Dicker, Adam P.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (01): : 87 - 87
[10] Immune thrombocytopenia after immune checkpoint inhibitor therapy
Amanam, Idoroenyi
Gupta, Rohan
Pullarkat, Vinod
Mei, Matthew
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 677 - 681

← 1 2 3 4 5 →